SYBX
SYNLOGIC, INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 18 ▼ Nasdaq has finalized the delisting of Synlogic, Inc. (SYBX) common s…
- Jul 27 ▲ 1 insider buy $0.00
- Jul 29 ▼ Synlogic (SYBX) has entered into a definitive merger agreement with…
- Aug 14 ▲ Short interest falls 85.8% to 5.1K
- Aug 31 ▲ Short interest falls 30.1% to 3.6K
Signal stack
Where each data set points today.
- InsidersMIXED
No open-market sales.
- InstitutionsMIXED
Q4 2025: 1 added (0 new), 0 trimmed or exited.
- Short sellersSTEADY
Short interest 0.0% to 2.9K shares. 1.0 days to cover.
- TrendRANGE
1% above its 50-day average.
Who's buying
13F· Q4 2025| Fund | Move | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | $95.9K |
| RENAISSANCE TECHNOLOGIES LLC | ADD | $65.9K |
| FMR LLC | NEAR_EXIT | $9.0K |
| JPMORGAN CHASE & CO | NEAR_EXIT | $1.00 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $31.2K |
| FMR LLC | TRIM | $248.4K |
| CITADEL ADVISORS LLC | TRIM | $24.5K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Mar 2024| Date | Firm | Rating |
|---|---|---|
| Mar 20, 2024 | HC Wainwright & Co. UPGRADE | Neutral |
| Feb 9, 2024 | Chardan Capital DOWNGRADE | Neutral |
| Feb 9, 2024 | Leerink Partners DOWNGRADE | Market Perform |
| Feb 9, 2024 | HC Wainwright & Co. DOWNGRADE | Sell |
| Dec 11, 2023 | Alliance Global Partners INITIATE | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
New Enterprise Associates 14, L.P. Director Jul 27, 2026 | BUY | 2,640,845 sh |
New Enterprise Associates 14, L.P. Director Jul 27, 2026 | EXPIRED | 2,640,845 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 30, 2026SecBot reports
5 filings · 0 bullish · 2 bearish · 3 neutral- NEUTRAL 425Nov 5, 2026
Caldera Therapeutics, the private biotech merging with Synlogic (SYBX), announced positive Phase…
Monitor the effectiveness of the S-4 registration statement and shareholder votes for the merger, as well as the IND submission for CLD-423 Phase 2b UC trial expected in Q4 2026. The Phase 1a data…
- NEUTRAL 425Nov 2, 2026
Caldera Therapeutics, the private biotech merging with Synlogic (SYBX), announced the appointment…
The executive hires signal Caldera is building a public-company-ready leadership team ahead of the merger close. Monitor the S-4 effectiveness and stockholder vote timelines for the next catalyst.
- BEARISH 425, 8-KJul 29, 2026
Synlogic (SYBX) has entered into a definitive merger agreement with Caldera Therapeutics, a…
SYBX holders face near-total dilution to a ~2.3% stake in a new entity controlled by Caldera. The stock will likely trade down toward the implied deal value of ~$18M enterprise value. Monitor for…
- BEARISH 25-NSEMay 18, 2026
Nasdaq has finalized the delisting of Synlogic, Inc. (SYBX) common stock, effective May 28, 2026…
The delisting is already priced in as the stock has been suspended and trading OTC since January 21, 2026. This 25-NSE finalizes the deregistration process with the SEC. Traders should watch for any…
All SYBX filing & press-release reports (5)
- 425 reportNov 5, 2026
- 425 reportNov 2, 2026
- 425, 8-K reportJul 29, 2026
- 25-NSE reportMay 18, 2026
- 10-K/A reportApr 30, 2026